Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Xeris Biopharma Holdings Inc (NASDAQ: XERS) was $2.48 for the day, down -1.59% from the previous closing price of $2.52. In other words, the price has decreased by -$1.59 from its previous closing price. On the day, 0.85 million shares were traded. XERS stock price reached its highest trading level at $2.57 during the session, while it also had its lowest trading level at $2.43.
Ratios:
Our analysis of XERS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.81 and its Current Ratio is at 2.37.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on March 28, 2024, initiated with a Outperform rating and assigned the stock a target price of $5.
On August 28, 2023, Craig Hallum started tracking the stock assigning a Buy rating and target price of $4.50.
On October 21, 2022, Jefferies started tracking the stock assigning a Buy rating and target price of $4.Jefferies initiated its Buy rating on October 21, 2022, with a $4 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 10 ’24 when Schmid John P. bought 5,400 shares for $1.91 per share. The transaction valued at 10,314 led to the insider holds 16,400 shares of the business.
Schmid John P. bought 4,500 shares of XERS for $9,720 on Mar 14 ’24. The Director now owns 11,000 shares after completing the transaction at $2.16 per share. On Nov 27 ’23, another insider, SHERMAN JEFFREY W, who serves as the Director of the company, bought 5,400 shares for $1.87 each. As a result, the insider paid 10,098 and bolstered with 5,400 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, XERS now has a Market Capitalization of 375117344 and an Enterprise Value of 549017024. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.15. Its current Enterprise Value per Revenue stands at 3.204 whereas that against EBITDA is -16.797.
Stock Price History:
Over the past 52 weeks, XERS has reached a high of $3.26, while it has fallen to a 52-week low of $1.46. The 50-Day Moving Average of the stock is 10.96%, while the 200-Day Moving Average is calculated to be 13.76%.
Shares Statistics:
XERS traded an average of 1.34M shares per day over the past three months and 1088400 shares per day over the past ten days. A total of 138.13M shares are outstanding, with a floating share count of 137.79M. Insiders hold about 7.06% of the company’s shares, while institutions hold 38.60% stake in the company. Shares short for XERS as of 1721001600 were 11410828 with a Short Ratio of 8.50, compared to 1718323200 on 11087972. Therefore, it implies a Short% of Shares Outstanding of 11410828 and a Short% of Float of 7.89.
